Investing in Maternal, Child and Adolescent Health

Abstract*

The objective of the Investing in Maternal, Child and Adolescent Health Project in Senegal is to improve utilization of essential reproductive, maternal, neonatal, child and adolescent health and nutrition (RMNCAH-N) services meeting quality standards in Priority Regions. This project consists of four components. Component one will support key interventions to overcome bottlenecks identified as major constraints for health system performance and effective...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The proposed Project Development Objective is to improve utilization of essential reproductive, maternal, neonatal, child and adolescent health and nutrition (RMNCAH-N) services meeting quality standards in Priority Regions.

Key Details

Project Details

  • P162042

  • Active

  • Christophe Lemiere , Aida Gadiaga

  • Republic of Senegal

  • Senegal

  • May 31, 2018

  • (as of board presentation)

    September 26, 2019

  • April 14, 2020

  • US$ 150.00 million

  • Ministry of Health and Social Action

  • Western and Central Africa

  • 2020

  • US$ 150.00 million

  • B

  • Not Applicable

  • December 31, 2025

  • Yes

  • Bank Approved

  • June 18, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Global Financing Facility 10.00
IDA Credit 140.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 140.00
IBRD + IDA Commitment 140.00
Lending Instrument
Grant Amount 10.00
Total Project Cost** 150.00

Summary Status of World Bank Financing (US$ Millions) as of October 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of October 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Financial Management Moderately Unsatisfactory 2025-06-19
Monitoring and Evaluation Moderately Satisfactory 2025-06-19
Overall Implementation Progress (IP) Moderately Satisfactory 2025-06-19
Procurement Moderately Satisfactory 2025-06-19
Progress towards achievement of PDO Moderately Satisfactory 2025-06-19
Project Management Moderately Satisfactory 2025-06-19

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Completion rate for ANCsValue55.5068.4081.00
    DateDecember 28, 2018June 5, 2024December 31, 2024
    Comment
  • Contraceptive prevalence rate (Percentage)Value26.0025.6036.00
    DateJuly 8, 2019June 5, 2024December 31, 2024
    Comment
  • Percentage of children under 5 suffering from childhood stunting in SenegalValue17.0017.5010.00
    DateJune 30, 2017June 5, 2024December 31, 2024
    Comment
  • Percentage of children under 5 suffering from childhood stunting in the priority regionsValue22.3018.7010.00
    DateDecember 31, 2019June 5, 2024December 31, 2024
    Comment
  • Utilization of health services by patients covered by a community-based insurance mechanismValue15.0045.0040.00
    DateJuly 8, 2019June 5, 2024December 31, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Adolescent girls not pregnant among cash transfer beneficiariesValue0.00100.0096.00
    DateMay 30, 2019June 5, 2024December 31, 2024
    Comment
  • Adolescent girls who benefited from cash transfersValue0.00900.0049391.00
    DateJuly 8, 2019June 5, 2024December 31, 2024
    Comment
  • Completion rate of health facilities data reportsValue91.5025.1099.00
    DateMay 30, 2019June 5, 2024December 31, 2024
    Comment
  • Functional health posts in the intervention areaValue572.00603.00616.00
    DateJanuary 3, 2022June 5, 2024December 31, 2024
    Comment
  • Maturity level achieved on the WHO Global Benchmarking Tool for evaluation of national regulatory systems of medical productsValue1.003.003.00
    DateJanuary 4, 2021June 5, 2024December 31, 2024
    Comment
  • Midwives for 1,500 women of reproductive ageValue0.781.191.00
    DateJanuary 4, 2021June 5, 2024December 31, 2024
    Comment
  • Number of beneficiaries of the CBHISValue816393.004932038.002837532.00
    DateDecember 31, 2018June 18, 2024December 31, 2024
    Comment
  • Number of children immunizedValue0.00594877.00826108.00
    DateJuly 8, 2019June 5, 2024December 31, 2024
    Comment
  • Number of deliveries attended by skilled health personnelValue0.00532476.00869587.00
    DateSeptember 18, 2018June 5, 2024December 31, 2024
    Comment
  • Number of vulnerable beneficiaries (children aged 0-5) covered by the CBHISValue0.00415277.00954465.00
    DateMay 30, 2019June 5, 2024December 31, 2024
    Comment
  • Number of vulnerable beneficiaries (pregnant women) covered by the CBHISValue0.0044321.00184830.00
    DateDecember 31, 2020June 5, 2024December 31, 2024
    Comment
  • Number of women and children who have received basic nutrition servicesValue0.001482673.001148169.00
    DateSeptember 18, 2018June 5, 2024December 31, 2024
    Comment
  • Nurses per 5,000 PopulationValue0.340.671.00
    DateJanuary 4, 2021June 5, 2024December 31, 2024
    Comment
  • People who have received essential health, nutrition, and population (HNP) servicesValue0.002610026.002843864.00
    DateJuly 8, 2019June 5, 2024December 31, 2024
    Comment
  • People who have received essential health, nutrition, and population (HNP) services - Female (RMS requirement)Value0.000.000.00
    Date
    Comment
  • Percentage of deliveries in health facilitiesValue60.0092.0080.00
    DateDecember 31, 2019June 5, 2024December 31, 2024
    Comment
  • Utilisation rate of modern contraceptive methods by adolescent girls in a relationship, aged 15-19Value8.009.8018.50
    DateSeptember 19, 2018June 5, 2024December 31, 2024
    Comment
  • Women benefiting from revolving creditValue0.000.009000.00
    DateJanuary 4, 2021December 29, 2023December 31, 2024
    Comment